SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-588539
Filing Date
2016-05-12
Accepted
2016-05-12 12:59:29
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d175474d10q.htm 10-Q 229897
2 EXHIBIT 10.1 d175474dex101.htm EX-10.1 142341
3 EXHIBIT 10.2 d175474dex102.htm EX-10.2 14939
4 EXHIBIT 31.1 d175474dex311.htm EX-31.1 6189
5 EXHIBIT 31.2 d175474dex312.htm EX-31.2 8702
6 EXHIBIT 32.1 d175474dex321.htm EX-32.1 2890
7 EXHIBIT 32.2 d175474dex322.htm EX-32.2 2883
  Complete submission text file 0001193125-16-588539.txt   1706301

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pirs-20160331.xml EX-101.INS 158296
9 XBRL TAXONOMY EXTENSION SCHEMA pirs-20160331.xsd EX-101.SCH 27490
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20160331_cal.xml EX-101.CAL 35811
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20160331_def.xml EX-101.DEF 74846
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20160331_lab.xml EX-101.LAB 214935
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20160331_pre.xml EX-101.PRE 138122
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8794
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 161642738
SIC: 8731 Services-Commercial Physical & Biological Research